Akston Biosciences appoints John T. Preston as Board of Directors

Akston Biosciences Corporation, one of the clinical-stage biotechnology company, recently announced that John T. Preston, a founder of TEM Capital, has joined its Board of Directors. A recipient of numerous awards and previous advisor to several government agencies and expert witness for Congress, Preston brings to Akston his decades of experience in technology commercialization and intellectual […]